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An open prospective controlled study was designed to compare the efﬁcacy of short-term dynamic
group psychotherapy with the standard treatment in patients with depressive symptoms attended in
the primary care setting. A total of 115 patients with depressive symptoms were assigned to receive psy-
chotherapy (75min) over 9months (37 to 39 sessions) (n= 70) or the standard care (n=45). Outcome mea-
sures were the differences between baseline and post-treatment in the 17-item Hamilton Depression
Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HAM-A) and the Short-Form Health Survey
(SF-12) questionnaire in the two study groups. At the end of dynamic group psychotherapy, statistically
signiﬁcant improvements in the mean scores of all questionnaires were observed, whereas in control
patients, signiﬁcant improvements were only observed in the HDRS-17 scale and in the Mental Compo-
nent Summary score of the SF-12. The mean changes after treatment were also higher in the psychother-
apy group than in controls in all outcome measures, with statistically signiﬁcant differences in the mean
differences in favour of the psychotherapy group. In summary, implementation of short-term dynamic
group psychotherapy run by experienced psychotherapists for patients with depressive symptoms
attended in routine primary care centres is feasible and effective. © 2016 The Authors. Clinical
Psychology & Psychotherapy published by John Wiley & Sons Ltd.
Key Practitioner Message
• Short-term dynamic group psychotherapy was delivered as a non-pharmacological intervention to im-
prove depressive symptoms.
• Statistically signiﬁcant differences as compared with a control group were observed in 17-item Hamil-
ton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HAM-A) and the Short-Form
Health Survey (SF-12) questionnaire.
• Implementation of short-term dynamic group psychotherapy run by experienced psychotherapists for
patients with depressive symptoms attended in routine primary care centres is feasible and effective.
Keywords: Dynamic Group Psychotherapy, Primary Care, Depressive Symptoms, Prospective Controlled
Study
INTRODUCTION
Depressive disorders and their management is a great
concern because of the high prevalence and high burden
in terms of disability, treatment costs, effects of families
and carers, and loss of workplace productivity (Sobocki,
Jönsson, Angst, & Rehnberg, 2006; Mathers & Loncar,
2006; Gustavsson et al., 2011). Depression is a leading
cause of disability worldwide and a major contributor to
the global burden of disease (Ferrari et al., 2013; Miller,
Dell’Osso, & Ketter, 2014; WHO, 2015). Patients with men-
tal disorders receive treatment mostly in the context of pri-
mary care (Serrano-Blanco et al., 2010). More than 80% of
patients with depression are managed and treated in pri-
mary care, with those seen in secondary care being
skewed towards much more severe disease (Timonen &
Liukkonen, 2008). Depressed hospitalized patients differ
considerably in clinical characteristics from psychiatric
outpatient depressives, and clinical features inﬂuence the
family physician’s decision to treat with antidepressants
(Lampe, 2012).. Although primary care remains a major
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access point for the management of depression, signiﬁcant
shortcomings have been recognized in detection, prescrip-
tion of adequate antidepressant treatment and achieve-
ment of remission (Pence, O’Donnell, & Gaynes, 2012;
Unützer & Park, 2012; Lesage, 2015). By focusing mainly
on somatic complaints and diseases, general practitioners
often fail to identify an underlying mental disorder
(Minović et al., 2015). Also, clinically signiﬁcant depressive
symptoms are highly prevalent in primary care patients,
but the percentage of patients citing depression as a rea-
son for visit is markedly low (Zung, Broadhead, & Roth,
1993). In primary care settings, it has been shown that
screening programmes without substantial staff-assisted
depression care supports are unlikely to improve out-
comes (O’Connor, Whitlock, Beil, & Gaynes, 2009).
Most primary care physicians initiate and monitor treat-
ment of depression with various pharmacological agents,
but owing to time limitation, lack of knowledge or inexpe-
rience they are often unable to provide effective non-
pharmacological therapeutic modalities to their patients,
although psychotherapeutic interventions are recom-
mended by clinical practice guidelines (American Psychi-
atric Association, 2000a; National Institute for Health
and Care Excellence, 2010). In fact, depression can be ef-
fectively monitored in primary care if physicians follow
established guidelines and systematically track progress
(Manning & Jackson, 2015). Likewise, implementation of
a multi-component programme with clinical, educational
and organizational procedures in primary care has proven
to be effective (Aragonès et al., 2012).
Dynamically oriented psychotherapies are effective in-
terventions in a variety of mental disorders, including de-
pression. A recent meta-analysis in which 23 studies of
short-term psychodynamic psychotherapy for depression
were evaluated showed a signiﬁcant decrease in depres-
sive symptoms compared with control conditions
(Driessen et al., 2010). In a randomized pilot investigation,
moderate-to-large effect sizes in favour of a brief dynamic
psychotherapy as compared with treatment as usual were
reported in patients with moderate-to-severe depression
in the community mental health system (Gibbons et al.,
2012). However, detailed and reliable data characterizing
community-based psychodynamic group therapy in the
real-world setting is limited (Garland et al., 2010;
Lorentzen & Ruud, 2014). Moreover, clinical trials
assessing the effectiveness of psychodynamic psychother-
apy in patients with depressive symptoms selected by the
family physician and carried out in the primary care set-
ting are lacking.
Therefore, the objective of the present study was to eval-
uate through a prospective controlled clinical study, the
effectiveness of a short-term dynamic group psychother-
apy performed in the primary care setting and addressed
to patients with depressive symptoms referred to dynamic
group psychotherapy by family physicians themselves.
The ﬁnal goal was to determine whether results obtained
in an investigation close to the patient’s social and clinical
reality may help to design evidence-based speciﬁc effec-
tive interventions to improve the outcome of depression.
METHOD
Participants
A prospective open-label prospective and controlled
study was designed to test the hypothesis that short-term
dynamic group psychotherapy delivered in the primary
care setting could improve symptoms and quality of life
in patients with depressive symptoms attended by the
family physician. Between 2011 and 2013, patients aged
25years or older with depressive symptoms attended by
family physicians working in six primary care centres of
Santa Coloma de Gramenet, Barcelona (Spain) were eligi-
ble. Santa Coloma de Gramenet is an urban area adjacent
to the city of Barcelona, with a total population of 126 000
inhabitants. Patients with history or current use of canna-
bis, cocaine, heroin and alcohol were excluded from the
study, as were patients with borderline personality disor-
der, psychotic symptoms (delirium, hallucinations), cogni-
tive impairment of organic cause and ﬁbromyalgia. The
Mini-Mental State Examination (MMSE) was adminis-
tered to all patients older than 65 years of age to exclude
age-related cognitive dementia. The study was approved
by the Ethics Committee of Parc de Salut Mar, and written
informed consent was obtained from all patients.
Study Procedures
Informative sessions were carried out at each primary care
centre. The objective of these sessions was to explain the
audience the characteristics of group therapy for patients
with depressive symptoms, how it works and how it can
help.
Patients with depressive symptoms who met the inclu-
sion criteria were assigned to psychodynamic psychother-
apy (intervention) when they were referred by their
family physician within the time of recruitment of a group
therapy. A total of eight psychotherapy groups across the
3-year study period, with 75-min weekly sessions were
established. Duration of treatment was 9months (37–
39weeks). Typically, groups included eight or nine partic-
ipants and were closed to new participants after the third
session. Patients were stratiﬁed by ages (decades) for
treatment, so that psychotherapies were homogeneous
within a given age range. Instructions regarding the range
of age that patients should have to be included in psycho-
therapy groups were given to family physicians by elec-
tronic mail. Patients who were not referred within the
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time of recruitment of a group therapy were included in a
control group. The family physician was unaware of the
group (intervention or control) to which the patient was ﬁ-
nally included. All patients were initially interviewed by a
psychiatrist for clinical evaluation, to establish diagnoses
according to DSM IV criteria, and to complete the study
instruments. After 9months, patients and controls were
interviewed again to assess the clinical outcome.
Treatment
All dynamic psychotherapy sessions were performed in
two primary care centres. At the initial interview (assess-
ment visit), participants were explained that group psy-
chotherapy was a space that was sought that everyone
could think about and communicate their feelings. The ob-
jective of the group was to listen, be heard and to under-
stand what was explained. At the same time, this was an
opportunity to have a group experience and to under-
stand what happens in the group. Verbal or written infor-
mation was not provided.
The conceptual model followed the principles of psy-
chodynamic psychotherapy described by Blagys and
Hilsenroth (2000) emphasizing the following areas (with
the level of empirical support given in parentheses): (1) a
focus on affect and the expression of patient’s emotions
(strong support), (2) and exploration of patients’ attempts
to avoid topics or engage in activities that hinder the prog-
ress of therapy (strong support), (3) the identiﬁcation of
patterns in patients’ actions, thoughts, feelings, experi-
ences and relationships (strong support), (4) an emphasis
on past experiences (strong support), (5) a focus on a pa-
tients’ interpersonal experiences (strong support), (6) an
emphasis on the therapeutic relationship (moderate sup-
port), and (7) an exploration of patients’ wishes, dreams
or fantasies (moderate support).
The group psychotherapy technique is based on the con-
cept of the group as a unit of thought, shared most of the
time unconsciously, which allows highlighting the indi-
vidual characteristics of each member of the group (Bion,
1961). The role of the therapist to help the group to carry
out the task has been explicitly elaborated in the initial in-
terview. Within the framework described, therapists try to
clarify participants’ distressing situations, facilitate com-
munication and interpret the unconscious group dynam-
ics, with the aim to enable participants to gain more
insight. In this way participants can achieve a better un-
derstanding of themselves, improve interpersonal rela-
tionships, evolve improving symptoms and reach more
adaptive attitudes in everyday life. Treatment is not exclu-
sively directed to speciﬁc disorders.
Nondirective psychotherapy was conducted by a
psychiatrist–psychotherapist (aged 56years at the begin-
ning of the study) with more than 20-year experience in
group psychotherapy and with the collaboration of differ-
ent less experienced co-therapists in ﬁve of the eight psy-
chotherapies. Psychotherapists met regularly after
psychotherapy to assess the progress of treatment as well
as to discuss Yalom’s therapeutic factors, particularly
group cohesiveness, hope and interpersonal relationships
(Yalom, 2005). All the sessions were recorded on DVD to
verify a posteriori adaptation to manuals of group psy-
chotherapy and to perform further studies in the future.
Moreover, sessions were supervised regularly by an exter-
nal expert in group therapy.
Patients assigned to the control group were visited at
least once a month by their family physician.
Outcome Measures
Outcome measures included the 17-item Hamilton De-
pression Rating Scale (HDRS-17) and the Hamilton Anxi-
ety Rating Scale (HAM-A), total and subscale Psychic
Anxiety and Somatic Anxiety for the assessment of de-
pression and anxiety, respectively, and the 12-item Short-
Form Health Survey (SF-12) questionnaire for the assess-
ment of health-related quality of life. The SF-12 measures
eight health aspects, namely physical functioning, role
limitations because of physical health problems, bodily
pain, general health, vitality, social functioning, role limi-
tations because of emotional problems and mental health.
Two subscales are derived from the SF-12: the Physical
Component Summary (PCS) and the Mental Component
Summary (MCS). Higher scores represent better health
(scores greater than 50 represent above average health sta-
tus). Spanish validated versions of the HDRS-17 (Ramos-
Brieva & Cordero, 1986), HAM-A (Lobo et al., 2002), and
SF-12 (Schmidt et al., 2012) instruments were used. A
score< 7 in the HDRS-17 represents an absence of depres-
sive symptoms. Other data recorded included demo-
graphics (age, gender), diagnosis and antidepressant
treatment prescribed by the family physician. Psychiatric
diagnoses were established according to DSM-IV-TR
criteria (American Psychiatric Association, 2000b).
Statistical Analysis
Categorical variables were compared with the chi-square
(χ2) test or the Fisher’s exact probability test. Differences
in the HDRS-17, HAM-A (total score, psychic and somatic
subscales), and the Physical and Mental Components
Summary scores (PCS/MCS) of the SF-12 between base-
line and post-treatment (at 9months) in the intervention
and control groups were analysed with the Student’s t-test
for independent data. Mean differences of changes were
analysed with the Student’s t-test for paired data. The size
effect (standardized mean effect) was expressed as
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Cohen’s d. The relationship between initial severity of de-
pression and anxiety and improvement after treatment
was assessed with the Pearson’s ’product–moment corre-
lation coefﬁcient (r). Analyses were performed in the in-
tention to treat (ITT) data set (patients who attended at
least one group psychotherapy session and controls evalu-
ated at baseline) with the last observation carried forward
(LOCF) technique for missing data, and in the per-
protocol (PP) data set (patients who completed all dy-
namic group psychotherapy sessions and patients in the
control group evaluated at 9months). Statistical signiﬁ-
cance was set at p< 0.05. Data were analysed with the
SPSS-20 statistical programme.
RESULTS
The patient ﬂow is shown in Figure 1. A total of 122 pa-
tients referred by the family physician, 7 did not meet
the inclusion criteria at the initial interview. Of the remain-
ing 115 patients, 70 started dynamic group psychotherapy
and 45 were included in the control group. Twelve pa-
tients (17.1%) in the psychotherapy group and 14 (31.1%)
in the control group did not complete the 9-month study
period. Therefore, 58 patients completed all psychother-
apy group sessions and 31 patients in the control group
were evaluated at 9months. The ITT data set included
115 patients (dynamic group psychotherapy 70, controls
45) and the PP data set included 89 patients (dynamic
group psychotherapy 58, controls 31).
As shown in Table 1, the percentages of men and
women were higher and lower, respectively, in the psy-
chotherapy group than those in the control group
(p=0.038) but differences in age and psychiatric diagnosis
were not observed. Also, no signiﬁcant differences were
found between patients who completed the study and
those who did not regarding baseline demographic vari-
ables, psychiatric diagnoses and mean scores of anxiety,
depression and quality of life.
Except for two patients treated with benzodiazepines,
the remaining patients were treated with selective seroto-
nin re-uptake inhibitors (SSRIs) or serotonin and norepi-
nephrine re-uptake inhibitors (SNRIs in ﬁve patients) at
least for 3months before the assessment interview. Only
21% of the patients had been visited in specialized centres
on one or more occasions.
Figure 1. Flow chart of the patients included in the dynamic group psychotherapy and in the control group
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Table 2 shows the mean (SD) values of the HDRS-17,
HAM-A (total score, psychic and somatic subscales), and
the PCS and MCS scores of the SF-12 at baseline and at
the end of treatment in the intervention and the control
groups both in the analyses of the ITT and PP data sets.
At baseline the study sample was homogeneous with high
scores in the depression and anxiety scales and low qual-
ity of life. At the end of dynamic group psychotherapy,
statistically signiﬁcant improvements in the mean scores
of all questionnaires were observed, both in the ITT and
PP populations. In control patients, signiﬁcant improve-
ments were only observed in the HDRS-17 scale and in
the MCS score of the SF-12.
In both the ITT and PP data sets, the mean (SD) changes
after treatment were also higher in the psychotherapy
group than in controls in all outcome measures, with sta-
tistically signiﬁcant differences in the mean differences in
favour of the psychotherapy group: HAM-A total anxiety,
10.57 (95% conﬁdence interval [CI] 7.50–13.64, p< 0.001);
HDRS-17, 7.63 (95% CI 5.25–10.02, p< 0.001); PCS, 3.95
(95% CI 0.49–7.41, p=0.026) and MCS, 7.73 (95% CI
3.38–12.09, p=0.001) (Table 3). Large effect sizes were
found for improvements in total anxiety (d=1.25) and de-
pression (d=1.23) and medium effect sizes for improve-
ments in PCS (d=0.45) and MCS (d=0.64).
As shown in Figures 2 and 3, there was a statistically
signiﬁcant relationship between severity of anxiety and
depression at baseline and improvements after treatment
in the PP population (r=0.670, p< 0.001 for total anxi-
ety; r=0.692, p< 0.001 for depression). In the ITT popu-
lation, the relationship between severity of anxiety and
depression at baseline and improvements after treatment
was also statistically signiﬁcant (r= 0.591, p< 0.001 for
total anxiety; r=0.504, p< 0.001 for depression).
At the end of the study, the percentage of patients with
absence of depressive symptoms (score< 7 in the HDRS-
17) was 44.8% (26/58) in the dynamic group psychother-
apy and 12.9% (4/31) in the control group (p< 0.001).
To assess whether psychotherapy was consistent with
characteristics of dynamic psychotherapy reported by
Blagys and Hilsenroth (2000), a random sample of two
sessions recorded on DVD was evaluated by four inde-
pendent experts in psychotherapy. Of the 138 interven-
tions carried out by therapists in the two sessions, the
four experts agreed that 89% of the content corresponded
to the characteristics established by Blagys and Hilsenroth
(2000).
DISCUSSION
The present study evaluates the effect of adding dynamic
group psychotherapy to pharmacological treatment for
patients with depressive symptoms attended in the pri-
mary care setting. Short-term dynamic psychotherapy
(weekly sessions over a 9-month period) conducted by ex-
perienced psychotherapists and delivered at the primary
care centres was effective in reducing symptoms of anxi-
ety and depression, as well as improving health-related
quality of life. The effect size was very large for anxiety
and depression and moderate for quality of life. The mod-
erate effect size for the PCS and MCS of the SF-12 may be
explained by the presence of two psychotherapy groups
with patients older than 65years of age, in which the pres-
ence of other chronic conditions is common. Also, the ob-
servation of a signiﬁcant correlation between severity of
anxiety and depression at baseline and improvement after
treatment indicates that dynamic group psychotherapy is
Table 1. Demographic features and psychiatric diagnosis in the
study groups at the time of recruitment
Psychotherapy
group (n = 70)
Control group
(n= 45)
p
Value
Gender
Males 25 (35.7) 8 (17.8) .038
Females 45 (64.3) 37 (82.2)
Age, years, mean
(SD)
49.1 (15.04) 48.4 (12.3) .803
Diagnoses
Dysthymia 14 (20) 7 (15.5) .492
Cyclothymia 0 1 (2.2)
Major depressive
disorder
36 (51.4) 27 (60)
Adjustment
disorder
20 (28.6) 10 (22.2)
Completed the
study (n= 89)
Did not complete the
study (n= 26)
Gender
Males 25 (28.1) 8 (30.8) .790
Females 64 (71.9) 18 (69.2)
Age, years, mean
(SD)
48.5 (13.6) 50.0 (15.6) .624
Diagnoses
Major depressive
disorder*
49 (55.1) 15 (57.4) .543
Dysthymia 19 (21.3) 3 (11.5)
Adjustment
disorder
21 (23.6) 8 (30.8)
HAM-A, mean (SD)
Psychic anxiety 16.12 (4.78) 15.38 (3.99) .433
Somatic anxiety 12.08 (5.90) 12.38 (5.12) .797
Total score 28.15 (9.30) 27.53 (8.04) .737
HDRS-17 total
score, mean (SD)
20.23 (5.26) 19.38 (6.03) .581
PCS score, mean
(SD)
41.13 (8.70) 42.15 (10.27) .647
MCS score, mean
(SD)
30.34 (8.33) 31.19 (10.83) .712
*Included one case of cyclothymia.
Data as numbers and percentages in parenthesis unless otherwise stated.
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a valuable complementary strategy for patients with se-
vere disease. The fact that similar results were obtained
in the PP and ITT analyses (in ITT analysis the estimation
of the treatment effect is more conservative) adds strength
to the present ﬁndings.
In our country, it has been reported that about 70% of
patients with mental health disorders are exclusively
treated by family physicians (Serrano-Blanco et al., 2010).
Although depressive disorders are the most common
mental health problems in the community setting, screen-
ing instruments are not diagnostic tools and their use may
overestimate the prevalence of depression (Bros Cugat &
Jara Martin, 2015). Despite strong efforts, the diagnosis
and management of depression bring many challenges
in the primary care setting. There is no evidence from ran-
domized controlled trials (RCTs) of better health outcomes
as a result of screening for depression. In fact, there are nu-
merous factors suggesting that depression screening, even
with collaborative depression care, may not be beneﬁcial
for patients. These include the high rate of patients al-
ready treated, uncertainty about the ability of depression
screening tools to accurately identify previously unrecog-
nized patients and relatively small treatment effects
among patients with less severe depression who would
be most likely to be identiﬁed through screening. Accord-
ing to recommendations of the Canadian Task Force on
Preventive Health Care (CTFPHC), routine screening
would expose some patients to avoidable risks and would
pose a signiﬁcant cost burden (Thombs & Ziegelstein,
2013). Also, the United States Preventive Services Task
Force (USPSTF) recommendation to screen adults for de-
pression in primary care settings when staff-assisted de-
pression management programmes are available is not
supported by evidence from any RCTs that are directly
relevant to the recommendation (Thombs et al., 2014). In
our study, no routine screening method was used. Patients
with depressive symptoms were evaluated by the family
physician and diagnosis of depression conﬁrmed by
criteria of the DSM-IV-R. Then, patients who gave consent
were referred to dynamic group psychotherapy.
In terms of potential limitations, the non-blinded evalu-
ation of patients and the unknown number of patients
who were approached by the family physician and re-
fused treatment should be considered. However, in order
to cause a minimum interference in referrals, patients
were assigned to psychodynamic psychotherapy when
they were referred by the family physician within the time
of recruitment of a group therapy, otherwise they were in-
cluded as controls. Also, data were obtained from vali-
dated symptom-oriented measures and in real-world
clinical practice. The high percentage of women and the
distribution of diagnosis of severity of disease are
Table 2. Mean (SD) scores at baseline and at the end of the study in patients undergoing dynamic group psychotherapy and in
controls
Dynamic group psychotherapy Control group
No. patients Baseline Post-treatment p Value No. patients Baseline At 9months p Value
HAM-A
Psychic anxiety
ITT data set 70 15.43 (4.14) 10.13 (4.69) <.001 45 15.73 (4.25) 15.02 (5.23) .182
PP data set 58 15.62 (4.19) 9.22 (4.33) <.001 31 14.94 (3.59) 13.9 (4.95) .184
Somatic anxiety
ITT data set 70 12.53 (5.34) 6.87 (4.55) <.001 45 11.71 (4.61) 12.06 (5.91) .697
PP data set 58 12.74 (5.38) 5.91 (3.79) <.001 31 11.98 (5.24) 12.22 (6.05) .699
Total score
ITT data set 70 27.80 (8.39) 17.0 (8.25) <.001 45 27.47 (8.25) 27.24 (10.18) .830
PP data set 58 28.19 (8.64) 15.16 (7.25) <.001 31 26.29 (6.73) 25.97 (9.83) .831
HDRS-17 total score
ITT data set 70 19.26 (6.03) 9.73 (6.38) <.001 45 20.07 (5.59) 18.18 (6.36) .029
PP data set 58 19.31 (6.21) 7.81 (4.67) <.001 31 19.52 (5.79) 16.77 (6.45) .028
PCS score
ITT data set 70 41.37 (10.1) 44.19 (10.21) .010 45 42.79 (9.73) 43.29 (11.52) .428
PP data set 58 41.89 (10.36) 45.29 (10.27) .010 31 42.64 (10.3) 40.99 (10.8) .431
MCS
ITT data set 70 31.78 (11.3) 42.43 (10.89) <.001 45 29.78 (8.47) 33.18 (11.13) .020
PP data set 58 31.71 (12) 45.17 (10.13) <.001 31 30.21 (8.39) 35.16 (11.6) .019
HAM-A =Hamilton Anxiety Rating Scale. ITT = intention to treat. PP = per protocol. HDRS-17 = 17-item Hamilton Depression Rating Scale.
PCS = Physical Component Summary. MCS =Mental Component Summary.
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consistent with data reported in other studies (Ruiz, Silva,
& Miranda, 2001; Blackmore et al., 2009). The fact that age
limit was not an inclusion criteria may explain the high
mean age of our patients (49.1 years), and it has been
shown that dynamic group psychotherapy is beneﬁcial
for elderly people (Canete, Stormont, & Esquerro, 2000).
Patients discontinued group therapy mostly during the
ﬁrst sessions, as previously reported (Blackmore, Tantam,
Parry, & Chambers, 2012), although a more comprehen-
sive assessment of the indication of psychotherapy or in-
depth evaluation of the patients’ motivation may reduce
the number of patients lost to continue with treatment.
Table 3. Mean (SD) changes after treatment and mean differences in the two study groups
Mean (SD) changes after treatment Mean differences
(95% conﬁdence
interval)
p
ValueNo. patients Psychotherapy group No. patients Control group
HAM-A
Psychic anxiety
ITT data set 70 5.30 (5.36) 45 0.71 (3.52) 4.58 (2.94 to 6.23) <.001
PP data set 58 6.39 (5.26) 31 1.03 (4.22) 5.36 (2.94 to 6.23) <. 001
Somatic anxiety
ITT data set 70 5.65 (5.56) 45 0.24 (4.18) 5.90 (4.09 to 7.70) <.001
PP data set 58 6.82 (5.42) 31 0.35 (5.06) 7.18 (4.83 to 9.52) <. 001
Total score
ITT data set 70 10.08 (9.69) 45 0.22 (6.89) 10.57 (7.50 to 13.64) <.001
PP data set 58 23.03 (9.16) 31 0.32 (8.35) 12.71 (8.77 to 16.64) <. 001
HDRS-17 total score
ITT data set 70 9.52 (6.71) 45 1.88 (5.59) 7.63 (5.25 to 10.02) <.001
PP data set 58 11.50 (5.61) 31 2.74 (6.59) 8.75 (6.11 to 11.39) <. 001
PCS score
ITT data set 70 2.82 (8.90) 45 1.34 (9.50) 3.95 (0.49 to 7.41) .026
PP data set 58 3.40 (9.69) 31 1.64 (11.48) 5.05 (0.47 to 9.62) .031
MCS
ITT data set 70 11.14 (14.1) 45 3.40 (9.47) 7.73 (3.38 to 12.09) .001
PP data set 58 13.45 (14.7) 31 4.94 (11.13) 8.5 (2.57 to 14.3) .005
HAM-A =Hamilton Anxiety Rating Scale. ITT = intention to treat. PP = per protocol. HDRS-17 = 17-item Hamilton Depression Rating Scale.
PCS = Physical Component Summary. MCS =Mental Component Summary.
Figure 2. Correlation between severity of depressive symptoms
at baseline and improvement after treatment (PP population)
Figure 3. Correlation between severity of anxiety at baseline
and improvement after treatment (PP population)
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The number of patients lost to follow-up was greater
among controls. One of the reasons may be the lack of
contact with the research team over a long period of
9months.
Different studies, including an excellent systematic
review (Blackmore et al., 2009), have provided evidence of
the efﬁcacy of dynamic psychotherapy across a variety of
settings, conditions and measures (Crits-Christoph, 1992;
Piper et al., 2001; Shedler, 2010; Lorentzen, Ruud, Fjeldstad,
&Høglend, 2013), but to our knowledge data on the useful-
ness of dynamic group psychotherapy in patients with
depressive symptoms carried out by specialized psycho-
therapists in primary care centres have not been previously
reported.Ashort-termdynamicgrouppsychotherapy,with
a total of 37 to 39 sessions (75min weekly) was adequate to
the needs of our public health care services and seems to
be sufﬁcient to improve symptoms notably. In a recent
study, short- and long-term therapy seemed equally effec-
tive for typical outpatients seeking group psychotherapy
(Lorentzen et al., 2013).
The present study shows that implementation of short-
term dynamic group psychotherapy run by experienced
psychotherapists for patients with depressive symptoms
attended in routine primary care centres is feasible and
effective, with marked improvement in symptoms of
depression and anxiety, as well as in quality of life. These
ﬁndings, however, still need corroborating through other
research with a larger number of patients in the Spanish
population as well as in other patients attended in the pri-
mary health care systems of other countries. Assessment
of the variability among therapists to distinguish results
related to the therapists and results related to the method
is also a suggestive research line. Based on the recordings,
aqualitative study is currently being conducted, theprelim-
inary results of which indicate improvements in the pa-
tients’ capacity to symbolize and use of metaphors. Also
the items of Blagys and Hilsenroth (2000) that appeared
more frequently in our analysis are items (5) a focus on apa-
tients’ interpersonal experiences and (7) an exploration of
patients’wishes, dreams or fantasies.
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